Orthobiologics Market 2019 Leading by Prominent Companies such as ALLERGAN, 22APOTEX, ASTELLAS PHARMA, AUROBINDO PHARMA LIMITED, COGENTIX MEDICAL, ENDO INTERNATIONAL, HISAMITSU PHARMACEUTICAL

The global orthobiologics market is projected to register a CAGR of about 5.4% during the forecast period, 2018-2023. Orthobiologics are used by orthopedic surgeons to help injuries heal more quickly. They are used to quicken the healing of broken bones and injured muscles, tendons, and ligaments. These products are made from substances that are naturally found in our body.

Get Sample Copy of this report @ https://marketprognosis.com/sample-request/17150

Increasing Patient Preference for Minimally Invasive Procedures
Orthobiologic therapy is a minimally invasive therapy and one of the components of regenerative medicine that are used to treat several musculoskeletal ailments, including degenerative osteoarthritis. Lately, orthobiologics have come to be known as one of the prominent treatment option for early osteoarthritis (OA) of the knee. The interests about orthobiologcs in the medical community and growing research in the field of regenerative medicine, coupled with promising clinical results from the use of orthobiologics are helping to make the clinical applications of this treatment more diverse every day. Biological therapy or cellular arthroplasty is evolving rapidly in the management of OA. Repair of damaged cartilage and biological restitution can be possible by the judicious use of autologous biological products. This will help the orthobiologics market to flourish during the forecast period.

Key Developments:
• February 2018 - A conference was comducted that focused on orthobiologics at the Orthobiologic Singularity event, orthopedic medicine from invasive to regenerative.
• Sep 2017 - Bioventus, a global leader in orthobiologic solutions, announced that the US FDA approval was granted for DUROLANE, a single-injection, hyaluronic acid.

Major Players:
ALLERGAN PLC., APOTEX INC., ASTELLAS PHARMA INC., AUROBINDO PHARMA LIMITED, COGENTIX MEDICAL INC., ENDO INTERNATIONAL PLC, HISAMITSU PHARMACEUTICAL CO. INC., INTAS PHARMACEUTICALS LTD, JOHNSON & JOHNSON, MACLEODS PHARMACEUTICALS LTD, MEDTRONIC PLC, MYLAN NV, PFIZER INC., SANOFI, AND TEVA PHARMACEUTICAL INDUSTRIES LIMITED, amongst others.

Enquiry Before Buying @ https://marketprognosis.com/enquiry/17150

High Cost Associated with Orthobiologics-Based Treatments
Treatments involving orthobiologics are expensive and often not covered by the governments. This is owing to the fact that this form of treatment is relatively new and there have not been enough studies to prove their efficacy and effectiveness in treating the patients. Also, the possibility of alternative form of treatments mean that patients who are skeptical about this form of treatment can opt for other alternative treatments available. This will lead to the slowdown of the growth of this market.

North America to Maintain Lead in the Market
North America is expected to command the largest share of the market in 2017 due to the increasing incidence of spinal disorders, rising geriatric and obese population, growing preference for minimally invasive procedures, and growing physician and patient awareness about newly introduced treatment procedures and technologies. However, Asia Pacific is expected to register the highest growth rate during the forecast period. The presence of a large geriatric and target patient population, high incidence of osteoarthritis and obesity, increasing government spending on healthcare, and improving healthcare infrastructure are some of the major factors driving the growth of the Asia Pacific orthobiologics market.

Browse Report @ https://marketprognosis.com/report/global-orthobiologics-market---segmented-by-product,-disease,-end-user,-and-geography---growth,-trends,-and-forecast-%282018---2023%29/pr-17150

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMark Pvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.